<DOC>
	<DOCNO>NCT00440908</DOCNO>
	<brief_summary>The study prospective cohort trial utilize sequential laboratory result excess serum obtain hemodialysis patient ( act control ) . The objective study determine impact convert reuse single use dialyzer specific marker nutrition ( pre-albumin ) inflammation ( CRP ) hemodialysis patient follow period 6-months conversion . The Hypothesis : Comparing value obtain baseline value end 6-months conversion reuse single use patient : 1 . In patient baseline CRP &gt; 5 mg/L : Mean decrease 5 mg/L 2 . In patient baseline CRP &lt; 5 mg/L : &gt; 95 % remain &lt; 5 mg/L 3 . Mean serum pre-albumin level increase least 3 mg/dL . The study population drawn ~2,900 patient currently undergo hemodialysis 48 dialysis unit identify continue reuse dialyzer specifically use peracetic acid-based disinfectant ( Renalin® ) , February 1 , 2007 . These facility schedule convert single use dialyzer May December , 2007 . The selection patient depend solely facility conversion date , first-come , first-served basis . All patient within dialysis facility provide blood specimen routine monthly lab draw eligible . The facility patient enrol consecutively desired sample size approximately 2,500 patient reach</brief_summary>
	<brief_title>Inflammation Nutritional Parameters Hemodialysis Patients Using Reprocessed Dialyzers</brief_title>
	<detailed_description>The propose project ancillary quality improvement study intend prospectively track serum marker inflammation ( C-reactive protein CRP ) nutrition ( pre-albumin ) baseline ( within 2-months conversion reuse single use dialyzer ) end 6-month follow-up period conversion , maintenance hemodialysis patient . The first 2,500 patient potential pool ~2,900 patient 48 dialysis unit schedule convert reuse single use dialyzer , include study . Apart routine monthly laboratory measurement , investigator , collaboration Spectra Laboratories ( central lab ) perform measurement CRP pre-albumin excess blood ( routine blood chemistry obtain ) patient select part study cohort . It anticipate nature study quality improvement project , additional burden patient since test perform excess blood sample already send laboratory , utilization information aggregate identifiable personal health information allow study proceed without need inform consent individual patient . It hypothesize survival benefit observe epidemiological study ( include prior experience Fresenius Medical Care , North America ) may accompany and/or result , reduce inflammation and/or improvement nutritional status patient convert reuse single use dialyzer . The study compare difference value CRP pre-albumin separately , baseline end 6-months conversion . CRP level expect decline pre-albumin expected increase follow-up period . Even 20 % dropout rate , study expect &gt; 90 % power detect change CRP &gt; 3 mg/L &gt; 99 % power detect similar change pre-albumin . The patient study subset large epidemiological study examine impact convert reuse single use dialyzer patient survival .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patients undergoing hemodialysis 48 dialysis unit identify continue reuse dialyzer process peracetic acidbased disinfectant ( Renalin® ) , February 1 , 2007 . Hemodialysis patient currently reuse reprocess dialyzer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Dialyzer reuse</keyword>
	<keyword>Inflammatory marker</keyword>
	<keyword>Nutritional status</keyword>
</DOC>